Dysphotopsia after temporal versus superior laser peripheral iridotomy: a prospective randomized paired eye trial.

PURPOSE: To determine if the location of neodymium:yttrium-aluminum-garnet laser peripheral iridotomy (LPI) is related to the occurrence of postoperative visual dysphotopsia. DESIGN: Randomized, prospective, single-masked, paired-eye comparative clinical trial. METHODS: setting: Private subspecialty clinic in Mississauga, Canada. study population: Patients with primary angle closure or primary angle-closure suspects were recruited and randomized to receive LPI temporally in one eye and superiorly in the other. Patients were masked to the location of treatment in each eye. intervention: Temporal or superior LPI. main outcome measures: Occurrence of new-onset linear dysphotopsia. Other visual disturbances also were assessed using a questionnaire before and 1 month after intervention. Secondary outcome measures included eyelid position, laser parameters, and any intraoperative complications. RESULTS: A total of 208 patients were recruited to the study, of which 169 (84%) completed it. New-onset linear dysphotopsia was reported in 18 (10.7%) eyes with superior LPI versus 4 (2.4%) eyes with temporal LPI (P = .002). Eleven eyes (6.5%) with superior LPI reported linear dysphotopsia despite complete eyelid coverage of the iridotomy. No significant differences were found with other visual disturbances between them. There was more pain experienced by the temporal LPI (2.8 ± 2.2 vs 2.1 ± 2.0; P = .001), despite no difference in laser energy or number of shots. Intraoperative rates of hemorrhage were similar (8.9% vs 10.1%; P = .71). CONCLUSIONS: Temporal placement of LPI is safe and was found to be less likely to result in linear dysphotopsia as compared with superior placement. Temporal iris therefore may be considered a preferred location for LPI.

Using multiple trabecular micro-bypass stents in cataract patients to treat open-angle glaucoma.

PURPOSE: To evaluate the efficacy of multiple trabecular micro-bypass stents combined with cataract surgery in patients with open-angle glaucoma (OAG) and cataract. SETTING: Private practice, Mississauga, Ontario, Canada. DESIGN: Comparative case series. METHODS: Eyes with OAG had implantation of 2 or 3 micro-bypass stents with concurrent cataract surgery and follow-up through 1 year. Efficacy measures were intraocular pressure (IOP) and topical ocular hypotensive medication use. Safety assessment included complications and corrected distance visual acuity (CDVA). RESULTS: The study comprised 53 eyes (47 patients); 28 had implantation of 2 stents and 25 had implantation of 3 stents. The overall mean 1-year postoperative IOP was 14.3 mm Hg, which was significantly lower than preoperative IOP overall and in each group (P<.001). The target IOP was achieved in a significantly higher proportion of eyes at 1 year versus preoperatively (77% versus 43%; P<.001). Overall, 83% of eyes had a decrease in topical ocular hypotensive medication at 1 year from preoperatively, with a 74% decrease in the mean number of medications (from 2.7 to 0.7) at 1 year (P<.001). The 3-stent group was on significantly fewer medications than the 2-stent group at 1 year (0.4 versus 1.0; P=.04). CONCLUSIONS: Using multiple micro-bypass stents with concurrent cataract surgery led to a mean postoperative IOP of less than 15 mm Hg and allowed patients to achieve target pressure control with significantly fewer medications through 1 year. FINANCIAL DISCLOSURE: Dr. Ahmed is a consultant to Glaukos Corp. No other author has a financial or proprietary interest in any material or method mentioned.